Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
5
×
national blog main
national top stories
new york top stories
novartis
5
×
san francisco top stories
spinal muscular atrophy
5
×
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
medicare
parkinson's disease
celgene
deals
democrats
drug prices
eli lilly
What
bio
roundup
alzheimer’s
democrats
drug
ipo
new
allogene
america
approved
atrophy
biogen
cancer
companies
congress
continues
convoluted
crispr
daily
different
diversity
divided
dreams
elections
evrysdi
fail
fallout
fda
friday
gene
green
head
headaches
healthcare
holding
home
hot
immunotherapy
increases
insurance
Language
unset
Current search:
novartis
×
national
×
" spinal muscular atrophy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More